Multi-center phase II clinical trial of transarterial embolization using microsphere for painful bone tumors (JIVROSG-1106)
- Conditions
- painful bone tumors
- Registration Number
- JPRN-UMIN000026121
- Lead Sponsor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3
Not provided
1. Allergy to contrast media. 2. Active infection other than virus hepatitis. 3. Displaced fracture. 4. Uncontrollable pain due to the non-target bone lesion. 5. Radicular pain due to the target lesion. 6. Undetermined location of the pain. 7. Undetermined location of the target lesion on images. 8. Radiation therapy within 4 weeks. 9. Intent of preoperative embolization for bleeding control. 10. Need for transarterial therapies in 2 weeks after procedure. 11. Inability to keep the position during the procedure with drugs and physical therapies. 12. Uncontrollable coagulation disorders. 13. Pregnancy or possibility of pregnancy. 14. The physician in charge considers the patient unsuitable as the subject of this clinical trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of pain reduction at 2 weeks after the procedure.
- Secondary Outcome Measures
Name Time Method Frequency and grade of complications. Duration of effective pain reduction. Rate of significant pain reduction at 2 weeks after the procedure.